RT Journal Article
SR Electronic
T1 Esketamine: A Possible Adjunctive Therapy for Treatment Resistant Depression
JF The Journal of the American Board of Family
                Medicine
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 1120
OP 1122
DO 10.3122/jabfm.2025.250369R0
VO 38
IS 6
A1 Huang, Annie
A1 Fernandez Vasquez, Jennifer L.
A1 Yeager, Catherine A.
YR 2025
UL http://www.jabfm.org/content/38/6/1120.abstract
AB If available in one’s practice area, augmenting current medication therapy with esketamine results in greater rates of remission for treatment resistant depression as compared with quetiapine1.